SKIN — Skinhealth Systems Balance Sheet
0.000.00%
- $108.70m
- $240.41m
- $300.79m
Annual balance sheet for Skinhealth Systems, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-Q | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 902 | 568 | 523 | 370 | 233 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 51.4 | 77.8 | 55 | 28.5 | 23.4 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 1,001 | 783 | 698 | 477 | 310 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 31.2 | 33.8 | 26.3 | 19.6 | 14.1 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,219 | 1,003 | 929 | 686 | 500 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 76.4 | 71.7 | 115 | 68.2 | 186 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 917 | 836 | 870 | 634 | 439 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 302 | 167 | 59.4 | 51.8 | 61.1 |
| Total Liabilities & Shareholders' Equity | 1,219 | 1,003 | 929 | 686 | 500 |
| Total Common Shares Outstanding |